Investor teach-in

RNS Number : 8347M

Cambridge Cognition Holdings PLC

12 May 2015

 

12 May 2015

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Investor teach-in

Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests, will be hosting a teach-in where Nick Kerton, CEO and Nick Walters, CFO will provide an overview and strategy of the Company on Tuesday 2 June 2015. No new material trading or financial information will be disclosed.

The event is open to all investors and will be held from 16:30 for a 16:45 start in the Black Bar, 6 Adams Court, Old Broad Street, London, EC2N 1DX and will be followed by drinks and canapés.

To register for the event, please email [e-mail] or call the Walbrook PR team below.

Enquiries:

Cambridge Cognition Holdings plc	www.cambridgecognition.com
Nick Kerton, Chief Executive Officer	Tel: [phone]
Nick Walters, Chief Financial Officer
finnCap Ltd (Nomad and Broker)	Tel: [phone]
Geoff Nash/ Simon Hicks	(Corporate Finance)
Malar Velaigam	(Corporate Broking)
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

About Cambridge Cognition

Cambridge Cognition is a world leading provider of computerised cognitive assessment products.  The company's range of touch-screen CANTAB™ neuropsychological tests, highly validated over one thousand peer-reviewed publications, are used by both academic  scientists  in their research, and clinical researchers in the pharmaceutical industry, to maximise knowledge of cognitive function.  In addition, the company is committed to broadening the access to this technology and is developing clinical healthcare products under the Cantab mobile brand, to improve the monitoring, management and maintenance of cognitive health and wellbeing.  Using these assessments, clinicians can identify and stratify patients so that patient referrals are accurate and efficient, enabling health and social care providers to deliver more effective advice, treatments and care - leading to better outcomes for patients and their families. 

 

END

 

 

NRABLGDUGDBBGUB